EMA recommends Pandemrix for the under 20s only when seasonal vaccine unavailable
This article was originally published in Scrip
Executive Summary
The European Medicines Agency has recommended that GSK's pandemic flu vaccine, Pandemrix, be used in people aged under 20 only when seasonal trivalent vaccines are unavailable. But the recommendations may have little impact as few patients now receive immunisation with Pandemrix anyway.